Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
The Effects of an mRNA Covid-19 Vaccine Booster on Immune Responses in Cancer-Bearing Veterans.
Journal: Medical research archives
Published: November 21, 2022
Bioinformatic Analysis Underpinning the Frequent Occurrence of Immune Thrombocytopenic Purpura in COVID-19 Patients.
Journal: The Israel Medical Association journal : IMAJ
Published: May 22, 2022
First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors.
Journal: EClinicalMedicine
Published: April 19, 2021
Unbiased Microbiome and Metabolomic Profiling of Fecal Samples from Patients with Melanoma.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: March 11, 2021
Response to pegylated interferon in a COVID-19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus.
Journal: Clinical case reports
Published: February 08, 2021
Response to pegylated interferon in a COVID-19-positive elderly woman with primary myelofibrosis treated with ruxolitinib.
Journal: Clinical case reports
Published: January 15, 2021
A Phase I/Ib Trial of PD 0332991 (Palbociclib) and T-DM1 in HER2-Positive Advanced Breast Cancer After Trastuzumab and Taxane Therapy.
Journal: Clinical breast cancer
Published: November 12, 2020
Epidermal growth factor receptor-activating mutation(E746_T751>VP) in pancreatic ductal adenocarcinoma responds to erlotinib, followed by epidermal growth factor receptor resistance-mediating mutation (A647T): A case report and literature review.
Journal: Journal of cancer research and therapeutics
Published: September 15, 2020
Exosomal markers (CD63 and CD9) expression and their prognostic significance using immunohistochemistry in patients with pancreatic ductal adenocarcinoma.
Journal: Journal of gastrointestinal oncology
Published: August 09, 2019
Last Updated: 09/26/2026